Targeting Histone Deacetylases in Neuroblastoma

E-ISSN： 1873-4286|15|4|436-447

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.4, 2009-02, pp. : 436-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting histone deacetylases for heart failure

By Bush Erik W McKinsey Timothy A

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 767-784

Informa Healthcare

Access to resources Recommend Favorite

Targeting class I histone deacetylases in cancer therapy

By Delcuve Geneviève P Khan Dilshad H Davie James R

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 84-107

Bentham Science Publishers

Access to resources Recommend Favorite

Assays for Histone Deacetylases

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases as Targets for Multiple Diseases

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1005-1026

Bentham Science Publishers

Access to resources Recommend Favorite